Patent details

301267 Product Name: Pombiliti (cipaglucosidase alfa)

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301267
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3201320
Status:
Withdrawn
Application number:
301267
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1714
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/03/2023
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
03/04/2024
First Marketing Authorization date:
24/03/2023
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
04/04/2024
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
03/11/2025
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
03/04/2024
 
 

 

Name:
Amicus Therapeutics, Inc.
Address:
3675 Market Street, 19104, Philadelphia, PA , United States of America (US)

Agent

Name:
ir. A. Blokland c.s.
From:
03/04/2024
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
45/25
Publication date:
05/11/2025
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
15/24
Publication date:
10/04/2024
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
03/11/2025 Incoming Correspondence Electronic Withdrawal application 1 PDF /1/5/6/7/8/0800987651/docs/301267_12_incomingcorrespondenceelectronic20251103035603045.pdf
03/11/2025 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /1/5/6/7/8/0800987651/docs/301267_13_301267681222l193.pdf
05/06/2025 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/5/6/7/8/0800987651/docs/301267_11_incomingcorrespondencepaper20250605101758386.pdf
05/04/2024 Outgoing Correspondence Confirmation receipt request 2 PDF /1/5/6/7/8/0800987651/docs/301267_0_599429l174.pdf
04/04/2024 SPC Documents Accompanying letter SPC 3 PDF /1/5/6/7/8/0800987651/docs/301267_10_supplprotectioncertificate20240404034722495.pdf
03/04/2024 Application Form First filed application form 4 PDF /1/5/6/7/8/0800987651/docs/301267_1_applicationform20240404025110064.pdf
03/04/2024 SPC Documents Summary of the characteristics of the product 17 PDF /1/5/6/7/8/0800987651/docs/301267_2_supplprotectioncertificate20240404025814541.pdf
03/04/2024 SPC Documents Annex SPC 3 PDF /1/5/6/7/8/0800987651/docs/301267_3_supplprotectioncertificate20240404025814560.pdf
03/04/2024 SPC Documents Annex SPC 177 PDF /1/5/6/7/8/0800987651/docs/301267_4_supplprotectioncertificate20240404025924489.pdf
03/04/2024 SPC Documents Annex SPC 17 PDF /1/5/6/7/8/0800987651/docs/301267_5_supplprotectioncertificate20240404025814574.pdf
03/04/2024 SPC Documents Marketing Authorization SPC 4 PDF /1/5/6/7/8/0800987651/docs/301267_6_supplprotectioncertificate20240404030014833.pdf
03/04/2024 SPC Documents Annex SPC 11 PDF /1/5/6/7/8/0800987651/docs/301267_7_supplprotectioncertificate20240404025417165.pdf
03/04/2024 SPC Documents Annex SPC 2 PDF /1/5/6/7/8/0800987651/docs/301267_8_supplprotectioncertificate20240404030107165.pdf
03/04/2024 SPC Documents Annex SPC 37 PDF /1/5/6/7/8/0800987651/docs/301267_9_supplprotectioncertificate20240404025950833.pdf